ARRY:NSD-Array BioPharma Inc. (USD)

EQUITY | Solar | NASDAQ Global Market

Last Closing

USD 6.62

Change

-0.25 (-3.64)%

Market Cap

USD 1.31B

Volume

3.45M

Analyst Target

USD 44.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Solar

Symbol Name Price(Change) Market Cap
FSLR First Solar Inc

+2.13 (+1.37%)

USD 15.09B
ENPH Enphase Energy Inc

+2.15 (+5.48%)

USD 6.14B
RUN Sunrun Inc

+0.64 (+9.34%)

USD 2.14B
SEDG SolarEdge Technologies Inc

+1.26 (+7.59%)

USD 1.17B
SHLS Shoals Technologies Group Inc

+0.41 (+9.51%)

USD 0.77B
CSIQ Canadian Solar Inc

+0.19 (+1.84%)

USD 0.66B
CSLR Complete Solaria, Inc. Common ..

+0.12 (+9.52%)

USD 0.13B
PN Skycorp Solar Group Limited Or..

-0.04 (-1.37%)

USD 0.11B
SMXT Solarmax Technology Inc. Commo..

-0.03 (-2.56%)

USD 0.05B
TYGO Tigo Energy Inc.

-0.04 (-3.86%)

USD 0.05B

ETFs Containing ARRY

CTEX ProShares S&P Kensho Clea.. 4.48 % 0.00 %

+0.03 (+-0.22%)

USD 1.47M
ZERO:PA 3.92 % 0.00 %

N/A

N/A
WRNW:XETRA WisdomTree Renewable Ener.. 3.27 % 0.00 %

-0.11 (-0.22%)

N/A
SOLR:SW Invesco Solar Energy UCIT.. 3.20 % 0.00 %

+0.36 (+-0.22%)

N/A
LUSA:LSE Rize USA Environmental Im.. 1.85 % 0.00 %

-0.01 (-0.22%)

USD 0.01B
PBD Invesco Global Clean Ener.. 0.00 % 0.75 %

-0.02 (-0.22%)

N/A
TAN Invesco Solar ETF 0.00 % 0.65 %

+0.42 (+-0.22%)

N/A
CLMT:CA 0.00 % 0.00 %

N/A

N/A
RENW:XETRA L&G Clean Energy UCITS ET.. 0.00 % 0.00 %

+0.02 (+-0.22%)

N/A
RAYS Global X Solar ETF 0.00 % 0.00 %

+0.10 (+-0.22%)

USD 4.23M
RAYG:LSE Global X Solar UCITS ETF .. 0.00 % 0.00 %

-0.01 (-0.22%)

USD 3.89M
ZER0:XETRA 0.00 % 0.00 %

N/A

N/A
RA7Z:XETRA Global X Solar UCITS ETF .. 0.00 % 0.00 %

-0.02 (-0.22%)

USD 3.23M
RAYZ:LSE Global X Solar UCITS ETF .. 0.00 % 0.00 %

-0.02 (-0.22%)

N/A
TANN:AU 0.00 % 0.00 %

N/A

N/A
RAYZ:SW Global X Solar UCITS ETF .. 0.00 % 0.00 %

+0.02 (+-0.22%)

USD 3.89M

Market Performance

  Market Performance vs. Industry/Classification (Solar) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.60% 79% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.60% 79% B- 79% B-
Trailing 12 Months  
Capital Gain -53.35% 43% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -53.35% 43% F 17% F
Trailing 5 Years  
Capital Gain -86.17% 22% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -86.17% 22% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -19.12% 43% F 15% F
Dividend Return -19.12% 43% F 15% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 59.51% 33% F 30% F
Risk Adjusted Return -32.13% 57% F 22% F
Market Capitalization 1.31B 76% C+ 69% C-

Key Financial Ratios

  Ratio vs. Industry/Classification (Solar) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 62.00 27% 16%
Price/Book Ratio 5.03 37% 23%
Price / Cash Flow Ratio 4.97 33% 41%
Price/Free Cash Flow Ratio 9.74 33% 37%
Management Effectiveness  
Return on Equity -53.46% 65% 30%
Return on Invested Capital -19.20% 59% 33%
Return on Assets 3.87% 90% 80%
Debt to Equity Ratio 223.85% 17% 10%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector